Growth Metrics

Alnylam Pharmaceuticals (ALNY) Shareholder's Equity (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 36.27%
Dec 31, 2025 237.41%
Sep 30, 2025 -6.66%
Jun 30, 2025 -41.20%
Mar 31, 2025 535.20%
Dec 31, 2024 107.36%
Sep 30, 2024 1,154.91%
Jun 30, 2024 98.60%
Mar 31, 2024 0.62%
Dec 31, 2023 -33.03%
Sep 30, 2023 59.36%
Jun 30, 2023 -57.43%
Mar 31, 2023 -63.84%
Dec 31, 2022 -133.93%
Sep 30, 2022 -138.42%
Jun 30, 2022 -56.12%
Mar 31, 2022 -31.80%
Dec 31, 2021 -22.18%
Sep 30, 2021 -11.42%
Jun 30, 2021 -7.86%
Mar 31, 2021 -8.86%
Dec 31, 2020 -16.36%
Sep 30, 2020 -13.20%
Jun 30, 2020 3.70%
Mar 31, 2020 -6.18%
Dec 31, 2019 -10.48%
Sep 30, 2019 -8.54%
Jun 30, 2019 13.59%
Mar 31, 2019 18.82%
Dec 31, 2018 -11.92%
Sep 30, 2018 -8.80%
Jun 30, 2018 -7.64%
Mar 31, 2018 -0.66%
Dec 31, 2017 66.83%
Sep 30, 2017 -5.71%
Jun 30, 2017 35.15%
Mar 31, 2017 -9.71%
Dec 31, 2016 -9.33%
Sep 30, 2016 -7.60%
Jun 30, 2016 -7.62%
Mar 31, 2016 -5.98%
Dec 31, 2015 -4.30%
Sep 30, 2015 -6.18%
Jun 30, 2015 -5.87%
Mar 31, 2015 59.84%
Dec 31, 2014 3.51%
Sep 30, 2014 -4.01%
Jun 30, 2014 -1.33%
Mar 31, 2014 253.24%
Dec 31, 2013 -9.15%
Sep 30, 2013 -3.44%
Jun 30, 2013 -1.09%
Mar 31, 2013 132.41%
Dec 31, 2012 -24.33%
Sep 30, 2012 -5.91%
Jun 30, 2012 -4.61%
Mar 31, 2012 67.27%
Dec 31, 2011 -7.72%
Sep 30, 2011 -6.36%
Jun 30, 2011 -6.19%
Mar 31, 2011 -8.00%
Dec 31, 2010 -1.50%
Sep 30, 2010 -2.92%